Natixis’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257K | Buy |
+896
| New | +$257K | ﹤0.01% | 753 |
|
|
2025
Q1 | – | Sell |
-241
| Closed | -$85K | – | 1167 |
|
|
2024
Q4 | $85K | Buy |
+241
| New | +$85K | ﹤0.01% | 834 |
|
|
2024
Q3 | – | Sell |
-112
| Closed | -$35.7K | – | 1108 |
|
|
2024
Q2 | $35.7K | Sell |
112
-6,716
| -98% | -$2.14M | ﹤0.01% | 784 |
|
|
2024
Q1 | $1.57M | Sell |
6,828
-88
| -1% | -$20.2K | 0.01% | 449 |
|
|
2023
Q4 | $1.52M | Buy |
6,916
+6,211
| +881% | +$1.37M | 0.01% | 442 |
|
|
2023
Q3 | $159K | Sell |
705
-4,679
| -87% | -$1.06M | ﹤0.01% | 724 |
|
|
2023
Q2 | $1.19M | Buy |
5,384
+5,223
| +3,244% | +$1.15M | 0.01% | 500 |
|
|
2023
Q1 | $36.1K | Sell |
161
-9,039
| -98% | -$2.02M | ﹤0.01% | 838 |
|
|
2022
Q4 | $2.56M | Sell |
9,200
-45,800
| -83% | -$12.7M | 0.01% | 446 |
|
|
2022
Q3 | $11.5M | Buy |
55,000
+41,200
| +299% | +$8.63M | 0.05% | 249 |
|
|
2022
Q2 | $3.25M | Sell |
13,800
-110,500
| -89% | -$26M | 0.01% | 523 |
|
|
2022
Q1 | $22.3M | Buy |
124,300
+46,100
| +59% | +$8.27M | 0.08% | 238 |
|
|
2021
Q4 | $16.9M | Buy |
78,200
+3,200
| +4% | +$691K | 0.06% | 280 |
|
|
2021
Q3 | $13.8M | Buy |
+75,000
| New | +$13.8M | 0.05% | 299 |
|
|
2019
Q3 | – | Sell |
-67,758
| Closed | -$5.29M | – | 927 |
|
|
2019
Q2 | $5.29M | Buy |
67,758
+30,178
| +80% | +$2.36M | 0.04% | 313 |
|
|
2019
Q1 | $4.41M | Buy |
37,580
+18,821
| +100% | +$2.21M | 0.03% | 393 |
|
|
2018
Q4 | $2.04M | Buy |
+18,759
| New | +$2.04M | 0.02% | 420 |
|
|
2017
Q2 | – | Sell |
-2,116
| Closed | -$286K | – | 990 |
|
|
2017
Q1 | $286K | Buy |
+2,116
| New | +$286K | ﹤0.01% | 722 |
|